Unique therapeutic options matched to patient characteristics identified by real-world evidence (RWE)
- Interest and use of RWE in the pharmaceutical industry is expected to increase in the coming year, due to its role in regulatory approvals
- However, studies have shown that accuracy levels of electronic data can vary from as low as 30% to as high as 90%
- Where data is inaccurate, data enrichment will be required
- Pharmaceutical companies will continue to design observational studies to reinforce efficacy arguments
Click here to learn more
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.